Stocks Hitting 52-Week Lows - Teva Pharmaceutical Indus (NYSE:TEVA)

Juno Therapeutics Inc JUNO shares fell 6.3 percent to touch a new 52-week low of $19.14. Raymond James downgraded Juno Therapeutics from Outperform to Market Perform.
PDL BioPharma Inc PDLI shares touched a new 52-week low of $2.03. PDL BioPharma shares have dropped 42.94 percent over the past 52 weeks, while the S&P 500 index has gained 6.15 percent in the same period.
Coca-Cola European Partners plc CCE shares reached a new 52-week low of $31.09. Stifel Nicolaus downgraded Coca-Cola European Partners from Buy to Hold.
Teva Pharmaceutical Industries Ltd (ADR) TEVA shares fell 4.7 percent to reach a new 52-week low of $35.30. Teva named Dipankar Bhattacharjee as President and Chief Executive Officer, Global Generic Medicines Group. The company announced a positive outcome for COPAXONE® label in Europe and reaffirmed its 2016 guidance.